Skip to main content
SpringerLink
Log in

IFN-free therapy for HCV: higher costs than IFN-based therapy

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 Australian dollars

Reference

  • Lee AS, et al. The cost of successful antiviral therapy in hepatitis C patients: a comparison of IFN-free versus IFN-based regimens at an individual patient level in Australia. ClinicoEconomics and Outcomes Research 2017: 595-607, No. 9, 3 Oct 2017. Available from: URL: https://doi.org/10.2147/CEOR.S146280

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

IFN-free therapy for HCV: higher costs than IFN-based therapy. PharmacoEcon Outcomes News 789, 23 (2017). https://doi.org/10.1007/s40274-017-4430-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4430-9

Search

Navigation